comparemela.com

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Australia ,Liechtenstein ,Germany ,Melbourne ,Victoria ,Norway ,Iceland ,New Zealand ,Switzerland ,Deric Dube ,Thomas Hutter ,Emmanuelle Lecomte Brisset ,Vifor International ,Head Of Global Regulatory Affairs ,European Medicines Agency ,Travere Therapeutics Inc ,Fresenius Medical Care ,Committee For Medicinal Products Human Use ,University Hospital ,European Commission ,Nasdaq ,European Union ,Iga Nephropathy ,Travere Therapeutics ,Senior Professor ,Clinical Immunology ,Senior Vice President ,Global Regulatory Affairs ,Chief Executive Officer ,Medicinal Products ,Human Use ,Vifor Fresenius Medical Care Renal Pharma ,Orphan Drug Designation ,Drug Administration ,

comparemela.com © 2020. All Rights Reserved.